Parabilis Medicines, Inc. Shareholders' Equity
Parabilis Medicines, Inc. (PBLS) had Shareholders' Equity of $1.05 billion as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $1.05B.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$570.32M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$526.50M.
- 2025-06-30: Stockholders' Equity Attributable to Parent -$455.41M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $1.05B 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$570.32M 10-Q · filed 2026-08-13 |
| 2025-12-31 | -$526.50M 10-Q · filed 2026-08-13 |
| 2025-06-30 | -$455.41M 10-Q · filed 2026-08-13 |
| 2025-03-31 | -$421.43M 10-Q · filed 2026-08-13 |
| 2024-12-31 | -$383.94M 10-Q · filed 2026-08-13 |